2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1518938422 M.D.
Verify on CMS →

IGOR PRIVEN, M.D.

Endocrinology, Diabetes & Metabolism Physician in MANALAPAN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 526 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.7105/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$375.16
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

IGOR PRIVEN, M.D. reported a CMS MIPS final score of 90.7105/100 — above the 83.1 national average — and filed 2,954 Medicare Part D claims in 2023.

90.7105/100
MIPS score · +8 vs avg
3K
Part D claims, 2023
59%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

IGOR PRIVEN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 40% higher than 60% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

IGOR PRIVEN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about IGOR PRIVEN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 01/30/2006

NPI 1518938422

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

2,954 12% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

90.7105/100 7.610500000000002% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers

Endocrinology, Diabetes & Metabolism Physician share within New Jersey

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New Jersey

Medicare quality performance — MIPS

IGOR PRIVEN, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
90.7105/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 90.7105/100 vs national avg 83.1

0%100%National avg83%90.7%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 90.7105/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

IGOR PRIVEN, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 345 ROUTE 9 STE 8, MANALAPAN, NJ, 07726, with a listed phone of (732) 845-2200. NPI 1518938422 was issued on 01/30/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PRIVEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,954 prescription claims written by this provider, covering 526 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.7105/100 for the 2023 performance year (Quality 87.2742, Cost 63.0682), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

345 ROUTE 9 STE 8
MANALAPAN, NJ 07726

Provider Details

NPI 1518938422
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 01/30/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.7105
Final Score
Avg: 83.1
87.2742
Quality
63.0682
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where IGOR PRIVEN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MANALAPAN MEDICAL CENTER PA PC
OLD BRIDGE, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for IGOR PRIVEN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$375

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

IGOR PRIVEN, M.D. — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 2,954 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,954
Total Claims
$1.3M
Total Drug Cost
526
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,115
Total Day Supply
211,981
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$69K

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.35
Gender Split
60% female / 40% male
Age Distribution
<65: 27, 65-74: 261, 75-84: 190, 85+: 48

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What IGOR PRIVEN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
300
Metformin Hcl
196
Ozempic
Semaglutide
150
Atorvastatin Calcium
144
Synthroid
Levothyroxine Sodium
136
Jardiance
Empagliflozin
113
Metformin Hcl Er
Metformin Hcl
83
Acarbose
75
Repaglinide
73
Rosuvastatin Calcium
71

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How IGOR PRIVEN, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

IGOR PRIVEN, M.D.'s 2,954 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as PRIVEN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is IGOR PRIVEN, M.D.'s specialty?
IGOR PRIVEN, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MANALAPAN, New Jersey. Credentials: M.D..
How much does IGOR PRIVEN, M.D. prescribe under Medicare Part D?
In 2023, IGOR PRIVEN, M.D. wrote 2,954 Medicare Part D claims totaling $1.3M in drug costs for 526 beneficiaries.
What is IGOR PRIVEN, M.D.'s Medicare quality score?
IGOR PRIVEN, M.D. has a CMS MIPS Final Score of 90.7105/100 (Quality: 87.2742, Cost: 63.0682). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is IGOR PRIVEN, M.D. located?
IGOR PRIVEN, M.D. is located at 345 ROUTE 9 STE 8, MANALAPAN, NJ, 07726. Phone: (732) 845-2200.
What is IGOR PRIVEN, M.D.'s NPI number?
IGOR PRIVEN, M.D.'s National Provider Identifier (NPI) is 1518938422, issued on 01/30/2006.
Does IGOR PRIVEN, M.D. prescribe more brand-name or generic drugs?
IGOR PRIVEN, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $1.2M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does IGOR PRIVEN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, IGOR PRIVEN, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does IGOR PRIVEN, M.D. accept Medicare?
IGOR PRIVEN, M.D. appears in CMS Medicare data with 2,954 Part D claims and 526 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify IGOR PRIVEN, M.D.'s credentials?
IGOR PRIVEN, M.D.'s NPI is 1518938422 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology